Home - BMYscreen
wait
STRESS PATHWAYS
BMYSCREEN DEVELOPS BIOCHEMICAL OR CELL-BASED
LUMINESCENT ASSAYS FOR  STRESS PATHWAY MONITORING
IN-VITRO SCREENING
BMYSCREEN DEVELOPS AND MINIATURIZES
BIOCHEMICAL ASSAYS FOR DRUGS DISCOVERY
TISSUE BIOMARKERS
BMYSCREEN PROVIDES SOLUTIONS FOR QUANTIFICATION
OF PROTEIC BIOMARKERS IN COMPLEX TISSUES
BIOMOLECULAR INTERACTIONS
BMYSCREEN TECHNOLOGIES ENABLE ANALYSIS AND SCREENING
FOR DRUGS TARGETING BIOMOLECULAR INTERACTIONS
FOCUS ON CANCER
BMYSCREEN BENEFITS FROM A STRONG EXPERTISE
IN CANCER BIOLOGY
CREDITS
PRIVATE COMPANIES WORKING WITH BMYSCREEN BENEFIT
FROM DOUBLING THE RESEARCH TAX CREDIT FOR R&D IN FRANCE
BMYSCREEN in a few words
BMYscreen is an independent joint structure created in 2014 in Bordeaux (France) under the auspices of the University of Bordeaux, INSERM and ADERA and sponsored by the Conseil Régional d’Aquitaine.
BMYscreen offers its long-standing expertise on advanced biotechnologies to companies and academic laboratories.
MISSION STATEMENT
The mission of BMYscreen is to provide advanced scientific knowledge for the development of specific assays and screens to support the discovery of biochemical modulators of stress pathways in health and diseases.
SERVICE OVERVIEW
BMYscreen provides assay development, in vitro screening and quantitative biomarker determination within R&D collaborations and fee for service contractual agreements.
TARGET MARKETS/INDUSTRIES
BMYscreen advanced knowledge of biochemical stress pathways effectively supports product development efforts in the field of therapeutics and functional foods for human and veterinary applications.
Close
Loading...
Wait
Please wait
Loading longer than expected.
Wait 30 more seconds   Reload